| We are pleased to announce the following CE activity is now available on www.powerpak.com |
|
|
|
|
Goal To educate oncology, managed care, and specialty pharmacists on the evolving management of patients with triple negative breast cancer (TNBC), including ensuring appropriate access to treatment, developing optimal toxicity prevention and management, and providing enhanced pharmaceutical care, thus leading to optimized outcomes. |
|
|
Learning Objectives Upon completion of this activity, participants should be better able to: |
|
• |
Describe the challenges of triple-negative breast cancer (TNBC) management |
|
• |
Discuss currently available and emerging TNBC therapies |
|
• |
Explain the role of biomarker testing in TNBC treatment selection |
|
• |
Formulate strategies to provide effective patient-centered care to patients with TNBC |
|
|
|
Agenda |
|
|
Introduction (5 minutes) Presentation (45 minutes) Conclusions & Question & Answer Session (10 minutes) |
|
|
How to Earn Credit Participants must 1) read the learning objectives and faculty disclosures; 2) attend and participate in the live webinar; and 3) complete the evaluation form directly after the event with a maximum of within 60 days of attending the live session. To answer the questions, click on your selected choice for each answer then proceed to the next question. Your credit will automatically uploaded to CPE Monitor. |
||||||||||||
|
Required Computer Hardware/Software Please ensure the computer system you plan to use meets the following minimum requirements: |
||||||||||||
|
||||||||||||
|
Accreditation Statements |
||||||||||||
|
||||||||||||
|
||||||||||||
